BACKGROUND Numerous studies concerning endometriosis and pain have been reported.
However, there is no consensus on the best method to evaluate pain in endometriosis and …

Endometriosis is one of the major causes of economic burden and compromised quality of
life in a very large percentage of Asian women. While it is perceived as a benign condition …

Hereditary breast and ovarian cancer is caused by a germline mutation in BRCA1 or BRCA2
genes. The frequency of germline BRCA1/2 gene mutation carriers and the ratio of germline …

Several clinical trials in women with endometriosis demonstrated that dienogest reduces
endometrial lesions and improves health-related quality of life (HRQoL). To assess HRQoL …

Objective Endometriosis is a complex disease, and pain is an important component of the
syndrome. One of the most used methods to assess pain is the visual analogue scale (VAS) …

Dienogest (DNG) is a progestin with highly selective progesterone activity and minimal
androgenic activity and is helpful in reducing endometriosis-related pain. This study …

Background Dienogest has been shown to substantially improve endometriosis-associated
symptoms such as debilitating chronic pelvic pain, and in turn, health-related quality of life …

Introduction: Dienogest (DNG) is an oral progestin, derivative of 19-nortestosterone, that has
recently been introduced for the treatment of endometriosis. Areas covered: This review …

Objective We aimed to elucidate the pathogenesis of ovarian cancer through the loss of
mismatch repair (MMR) proteins in women with Lynch syndrome (LS) in this report. Case …

Introduction The influence of deep infiltrating endometriosis (DIE) on sexual function has
been poorly studied. The aim of this study was to evaluate the impact of DIE on sexual …